MAPP BIOPHARMACEUTICAL, INC. secures contract for Human-Derived Monoclonal Antibodies (Mabs) And Viral Recombinant Antigens (Ags) 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits And Sets 541714 - Research And Development In Biotechnology (Except Nanobiotechnology)

United States, June 4 -- United States based MAPP BIOPHARMACEUTICAL, INC. has secured contract from Dept Of Defense for Human-Derived Monoclonal Antibodies (Mabs) And Viral Recombinant Antigens (Ags) 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits And Sets 541714 - Research And Development In Biotechnology (Except Nanobiotechnology). The value of the contract is worth 2000000 USD.

Published by HT Digital Content Services with permission from Pivotal Sources....